L-Arginine Reverses p47phox and gp91phox Expression Induced by High Salt in Dahl Rats

Hypertension

Volumn 42, Issue 5, 2003, Pages 1014-1020

  Fujii, Shigemoto ^b   Zhang, Ling ^b   Igarashi, Junsuke ^b   Kosaka, Hiroaki ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b NONE

Author keywords

Arginine; Cardiovascular diseases; Hypertension, sodium dependent; Nitric oxide; Rats, Dahl

Indexed keywords

ARGININE; HYDROGEN PEROXIDE; ISOPROSTANE DERIVATIVE; MESSENGER RNA; NITRIC OXIDE; PROTEIN P47PHOX; RAC1 PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; THROMBOXANE B2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR DISEASE; CELL FRACTIONATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HYPERTENSION; KIDNEY COLLECTING TUBULE; KIDNEY CORTEX; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; RAT STRAIN; SALT LOADING; SODIUM ABSORPTION; WESTERN BLOTTING;

ANIMALS; ARGININE; BLOOD PRESSURE; DINOPROST; F2-ISOPROSTANES; GENE EXPRESSION REGULATION; HYPERTENSION; KIDNEY CORTEX; MALE; MEMBRANE GLYCOPROTEINS; NADPH OXIDASE; NITRIC OXIDE; PHOSPHOPROTEINS; RATS; RATS, INBRED DAHL; RNA, MESSENGER; SODIUM CHLORIDE; THROMBOXANE B2;

EID: 0242609831     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000094557.36656.D0     Document Type: Article

References (50)

1. Laursen JB, Rajagopalan S, Galis Z, Tarpey M, Freeman BA, Harrison DG. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation. 1997;95:588-593.
2. Swei A, Lacy F, DeLano FA, Schmid-Schonbein GW. Oxidative stress in the Dahl hypertensive rat. Hypertension. 1997;30:1628-1633.
3. Meng S, Cason GW, Gannon AW, Racusen LC, Manning RD Jr. Oxidative stress in Dahl salt-sensitive hypertension. Hypertension. 2003;41: 1346-1352.
4. - and systolic blood pressure in mice. Circ Res. 2001;89:408-414.
5. Chabrashvili T, Tojo A, Onozato ML, Kitiyakara C, Quinn MT, Fujita T, Welch WJ, Wilcox CS. Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney. Hypertension. 2002;39:269-274.
6. Ago T, Kuribayashi F, Hiroaki H, Takeya R, Ito T, Kohda D, Sumimoto H. Phosphorylation of p47phox directs phox homology domain from SH3 domain toward phosphoinositides, leading to phagocyte NADPH oxidase activation. Proc Natl Acad Sci U S A. 2003;100:4474-4479.
7. Barry-Lane PA, Patterson C, van der Merwe M, Hu Z, Holland SM, Yeh ETH, Runge MS. p47phox is required for atherosclerotic lesion progression in ApoE-/- mice. J Clin Invest. 2001;108:1513-1522.
8. Lassegue B, Griendling KK. Out phoxing the endothelium: what's left without p47? Circ Res. 2002;90:123-124.
9. Hishikawa K, Oemar BS, Yang Z, Luscher TF. Pulsatile stretch stimulates superoxide production and activates nuclear factor-κB in human coronary smooth muscle. Circ Res. 1997;81:797-803.
10. Marumo T, Schini-Kerth VB, Fisslthaler B, Busse R. Platelet-derived growth factor-stimulated superoxide anion production modulates activation of transcription factor NF-kappaB and expression of monocyte chemoattractant protein 1 in human aortic smooth muscle cells. Circulation. 1997;96:2361-2367.
11. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res. 1994;74:1141-1148.
12. Fukui T, Ishizaka N, Rajagopalan S, Laursen JB, Capers Qt, Taylor WR, Harrison DG, de Leon H, Wilcox JN, Griendling KK. p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circ Res. 1997;80:45-51.
13. Kawazoe T, Kosaka H, Yoneyama H, Hata Y. Involvement of superoxide in acute reaction of angiotensin II in mesenteric microcirculation. Jpn J Physiol. 1999;49:437-443.
14. Kawazoe T, Kosaka H, Yoneyama H, Hata Y. Acute production of vascular superoxide by angiotensin II but not by catecholamines. J Hypertens. 2000;18:179-185.
15. Lavigne MC, Malech HL, Holland SM, Leto TL. Genetic demonstration of p47phox-dependent superoxide anion production in murine vascular smooth muscle cells. Circulation. 2001;104:79-84.
16. Chen PY, St John PL, Kirk KA, Abrahamson DR, Sanders PW. Hypertensive nephrosclerosis in the Dahl/Rapp rat: initial sites of injury and effect of dietary L-arginine supplementation. Lab Invest. 1993;68: 174-184.
17. Nishida Y, Ding J, Zhou MS, Chen QH, Murakami H, Wu XZ, Kosaka H. Role of nitric oxide in vascular hyper-responsiveness to norepinephrine in hypertensive Dahl rats. J Hypertens. 1998;16:1611-1618.
18. Raij L, Luscher TF, Vanhoutte PM. High potassium diet augments endothelium-dependent relaxations in the Dahl rat. Hypertension. 1988;12: 562-567.
19. Zhou MS, Nishida Y, Chen QH, Kosaka H. Endothelium-derived contracting factor in carotid artery of hypertensive Dahl rats. Hypertension. 1999;34:39-43.
20. Zhou MS, Kosaka H, Tian RX, Abe Y, Chen QH, Yoneyama H, Yamamoto A, Zhang L. L-Arginine improves endothelial function in renal artery of hypertensive Dahl rats. J Hypertens. 2001;19:421-429.
21. Zhang L, Kosaka H. Sex-specific acute effect of estrogen on endothelium-derived contracting factor in the renal artery of hypertensive Dahl rats. J Hypertens. 2002;20:237-246.
22. Ortiz PA, Garvin JL. Intrarenal transport and vasoactive substances in hypertension. Hypertension. 2001;38:621-624.
23. Dahl L, Heine M. Primary role of renal homografts in setting chronic blood pressure levels in rats. Circ Res. 1975;36:692-696.
24. Wilcox CS, Deng X, Welch WJ. NO generation and action during changes in salt intake: roles of nNOS and macula densa. Am J Physiol. 1998;274:R1588-R1593.
25. Kitiyakara C, Chabrashvili T, Jose P, Welch WJ, Wilcox CS. Effects of dietary salt intake on plasma arginine. Am J Physiol. 2001;280: R1069-R1075.
26. Stoos BA, Garcia NH, Garvin JL. Nitric oxide inhibits sodium reabsorption in the isolated perfused cortical collecting duct. J Am Soc Nephrol. 1995;6:89-94.
27. Plato CF, Stoos BA, Wang D, Garvin JL. Endogenous nitric oxide inhibits chloride transport in the thick ascending limb. Am J Physiol. 1999;276:F159-F163.
28. Hayakawa H, Coffee K, Raij L. Endothelial dysfunction and cardiorenal injury in experimental salt-sensitive hypertension: effects of antihypertensive therapy. Circulation. 1997;96:2407-2413.
29. Chen PY, Sanders PW. L-Arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats. J Clin Invest. 1991;88:1559-1567.
30. Keston AS, Brandt R. The fluorometric analysis of ultramicro quantities of hydrogen peroxide. Anal Biochem. 1965;11:1-5.
31. Kosaka H, Yoneyama H, Zhang L, Fujii S, Yamamoto A, Igarashi J. Induction of LOX-1 and iNOS expressions by ischemia-reperfusion of rat kidney and the opposing effect of L-arginine. FASEB J. 2003;17: 636-643.
32. Zou A-P, Li N, Cowley AW Jr. Production and actions of superoxide in the renal medulla. Hypertension. 2001;37:547-553.
33. Azzi A, Montecucco C, Richter C. The use of acetylated ferricytochrome c for the detection of superoxide radicals produced in biological membranes. Biochem Biophys Res Commun. 1975;65:597-603.
34. Gosgnach W, Messika-Zeitoun D, Gonzalez W, Philipe M, Michel JB. Shear stress induces iNOS expression in cultured smooth muscle cells: role of oxidative stress. Am J Physiol. 2000;279:C1880-C1888.
35. Morawietz H, Weber M, Rueckschloss U, Lauer N, Hacker A, Kojda G. Upregulation of vascular NAD(P)H oxidase subunit gp91phox and impairment of the nitric oxide signal transduction pathway in hypertension. Biochem Biophys Res Commun. 2001;285:1130-1135.
36. Laufs U, Adam O, Strehlow K, Wassmann S, Konkol C, Laufs K, Schmidt W, Bohm M, Nickenig G. Down-regulation of Rac-1 GTPase by estrogen. J Biol Chem. 2003;278:5956-5962.
37. Doi K, Akaike T, Horie H, Noguchi Y, Fujii S, Beppu T, Ogawa M, Maeda H. Excessive production of nitric oxide in rat solid tumor and its implication in rapid tumor growth. Cancer. 1996;77:1598-1604.
38. Patrono C, FitzGerald GA. Isoprostanes: potential markers of oxidant stress in atherothrombotic disease. Arterioscler Thromb Vasc Biol. 1997; 17:2309-2315.
39. Davi G, Alessandrini P, Mezzetti A, Minotti G, Bucciarelli T, Costantini F, Cipollone F, Bon GB, Ciabattoni G, Patrono C. In vivo formation of 8-epi-prostaglandin F2α is increased in hypercholesterolemia. Arterioscler Thromb Vasc Biol. 1997;17:3230-3235.
40. Pfeiffer S, Lass A, Schmidt K, Mayer B. Protein tyrosine nitration in mouse peritoneal macrophages activated in vitro and in vivo: evidence against an essential role of peroxynitrite. FASEB J. 2001;15:2355-2364.
41. McDonald KK, Zharikov S, Block ER, Kilberg MS. A caveolar complex between the cationic amino acid transporter 1 and endothelial nitric-oxide synthase may explain the "arginine paradox". J Biol Chem. 1997;272: 31213-31216.
42. Touyz RM, Chen X, Tabet F, Yao G, He G, Quinn MT, Pagano PJ, Schiffrin EL. Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H Oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II. Circ Res. 2002;90: 1205-1213.
43. Landmesser U, Cai H, Dikalov S, McCann L, Hwang J, Jo H, Holland SM, Harrison DG. Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension. 2002;40:511-515.
44. Nowicki PT, Flavahan S, Hassanain H, Mitra S, Holland S, Goldschmidt-Clermont PJ, Flavahan NA. Redox signaling of the arteriolar myogenic response. Circ Res. 2001;89:114-116.
45. Minuz P, Patrignani P, Gaino S, Degan M, Menapace L, Tommasoli R, Seta F, Capone ML, Tacconetti S, Palatresi S, Bencini C, Del Vecchio C, Mansueto G, Arosio E, Santonastaso CL, Lechi A, Morganti A, Patrono C. Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease. Circulation. 2002;106: 2800-2805.
46. Morrow J, Hill K, Burk R, Nammour T, Badr K, Roberts LJI. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA. 1990;87:9383-9387.
47. Fontana L, Giagulli C, Cominacini L, Pasini AF, Minuz P, Lechi A, Sala A, Laudanna C. Beta2 integrin-dependent neutrophil adhesion induced by minimally modified low-density lipoproteins is mainly mediated by F2-isoprostanes. Circulation. 2002;106:2434-2441.
48. Kromer B, Tippins J. Coronary artery constriction by the isoprostane 8-epi prostaglandin F2 alpha. Br J Pharmacol. 1996;119:1276-1280.
49. Cayatte AJ, Du Y, Oliver-Krasinski J, Lavielle G, Verbeuren TJ. Cohen RA. The thromboxane receptor antagonist S18886 but not aspirin inhibits atherogenesis in Apo E-deficient mice: evidence that eicosanoids other than thromboxane contribute to atherosclerosis. Arterioscler Thromb Vasc Biol. 2000;20:1724-1728.
50. Morrow JD, Frei B, Longmire AW, Gaziano JM, Lynch SM, Shyr Y, Strauss WE, Oates JA, Roberts LJ. Increase in circulating products of lipid peroxidation (F2-Isoprostanes) in smokers: smoking as a cause of oxidative damage. N Engl J Med. 1995;332:1198-1203.